SEARCH

SEARCH BY CITATION

References

  • Badri M, Lawn SD & Wood R (2006) Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study. Lancet 368, 12541259.
  • Bassett IV, Wang B, Chetty S et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. Journal of Acquired Immune Deficiency Syndrome 51, 135139.
  • Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
  • Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817824.
  • Brinkhof MW, Dabis F, Myer L et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization 86, 559567.
  • Bussmann H, Wester CW, Ndwapi N et al. (2008) Five-year outcomes of initial patients treated in Botswana’s National Antiretroviral Treatment Program. Journal of Acquired Immune Deficiency Syndrome 22, 23032311.
  • Calmy A, Pinoges L, Szumilin E et al. (2006) Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. Journal of Acquired Immune Deficiency Syndrome 20, 11631169.
  • Coetzee D, Hildebrand K, Boulle A et al. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. Journal of Acquired Immune Deficiency Syndrome 18, 887895.
  • Etard JF, Ndiaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. Journal of Acquired Immune Deficiency Syndrome 20, 11811189.
  • Fairall LR, Bachmann MO, Louwagie GM et al. (2008) Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archive of Internal Medicine 168, 8693.
  • Ferradini L, Jeannin A, Pinoges L et al. (2006) Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367, 13351342.
  • Ferradini L, Laureillard D, Prak N et al. (2007) Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. Journal of Acquired Immune Deficiency Syndrome 21, 22932301.
  • Giordano TP, Gifford AL, White AC Jr et al. (2007) Retention in care: a challenge to survival with HIV infection. Clinical infectious diseases 44, 14931499.
  • Harries AD, Gomani P, Teck R et al. (2004) Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Transactions of the Royal Society of Tropical Medicine and Hygiene 98, 695701.
  • Hogg RS, Bangsberg DR, Lima VD et al. (2006) Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. PLoS Medicine 3, e356.
  • Ive P, Kgokong BM, Fox M, Maskew M, MacPhail P & Sanne I (2009) Time from virologic failure to switching to second-line therapy in patients receiving ART in Johannesburg, South Africa. 16th Annual CROI Meeting, Montreal (Abstract 607).
  • Keiser O and the ART-LINC Collaboration of the IeDEA (2009) Switching to second-line ART, and mortality in resource-limited settings: collaborative analysis of treatment programs in Africa, Asia, and Latin America. 16th Annual CROI Meeting, Montreal (Abstract 608).
  • Khaim S, Jacques G, De Munter P, Huyst V, Lynen L & Hines J (2004a) Experience with a selection procedure for free ART for PLWHA at an NGO hospital in Cambodia. XV International AIDS conference, Bangkok (Abstract TuPeD4995).
  • Khaim S, Jacques G, De Munter P, Lynen L, Hines J & Thai S (2004b) Establishing a selection committee (SC) for free antiretroviral therapy (ART) in Cambodia: the experience of an NGO hospital. XV International AIDS conference, Bangkok (Abstract TuPeD4994).
  • Kitahata MM, Koepsell TD, Deyo RA et al. (1996) Physicians’ experience with the acquired immunodeficiency syndrome as a factor in patients’ survival. The New England journal of medicine 334, 701706.
  • Knobel H, Alonso J, Casado JL et al. (2002) Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. Journal of Acquired Immunodeficiency Syndrome 16, 605613.
  • Lawn SD & Wood R (2007) National adult antiretroviral therapy guidelines in South Africa: concordance with 2003 WHO guidelines? Journal of Acquired Immunodeficiency Syndrome 21, 121122.
  • Lawn SD, Myer L, Orrell C, Bekker LG & Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. Journal of Acquired Immunodeficiency Syndrome 19, 21412148.
  • Lawn SD, Myer L, Harling G et al. (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clinical Infectious Diseases 43, 770776.
  • Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. Journal of Acquired Immunodeficiency Syndrome 22, 18971908.
  • Lima VD, Harrigan R, Bangsberg DR et al. (2009) The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. Journal of Acquired Immunodeficiency Syndrome 50, 529536.
  • Lynen L, An S, Koole O et al. (2009) An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. Journal of Acquired Immunodeficiency Syndrome, in press.
  • Madec Y, Laureillard D, Pinoges L et al. (2007) Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. Journal of Acquired Immunodeficiency Syndrome 21, 351359.
  • Ministry of Health Cambodia, NCHADS Surveillance Unit (2008) Report of a Consensus Workshop: HIV estimates and projections for Cambodia, January 2006–December 2012.
  • Nachega JB, Hislop M, Dowdy DW et al. (2006) Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. Journal of Acquired Immunodeficiency Syndrome 43, 7884.
  • National AIDS Authority (2008) UNGASS Country Progress Report Cambodia. Available from: http://data.unaids.org/pub/Report/2008/cambodia_2008_country_progress_report_en.pdf. Accessed December 2008.
  • Petersen ML, Van Der Laan MJ, Napravnik S et al. (2008) Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification. Journal of Acquired Immunodeficiency Syndrome 22, 20972106.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 4, e298.
  • Royston P (2004) Multiple imputation of missing values. Stata Journal 4, 227241.
  • Sok S, Koole O, Thai S, Sokkab A, Sculier D & Lynen L (2008) Development of a tool for quality monitoring of an HIV database for an HIV program in Phnom Penh, Cambodia. XVII International AIDS conference, Mexico City (Abstract TUPE0339).
  • Stringer JS, Zulu I, Levy J et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. The Journal of the American Medical Association 296, 782793.
  • Thai S, Len A, De Munter P, Koole O, Schrooten W & Lynen L (2006) Freeware database for follow-up patients and programs. XVI International AIDS Conference, Toronto (Abstract THPE0183).
  • Walensky RP, Wood R, Weinstein MC et al. (2008) Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. Journal of Infectious Diseases 197, 13241332.
  • WHO (2003) Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach, 2003 revision. Available from: http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf. Accessed December 2008.
  • Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bulletin of the World Health Organization 85, 550554.